Literature DB >> 19246468

Analysis of risk factors for the removal of normal ovarian tissue during laparoscopic cystectomy for ovarian endometriosis.

Sachiko Matsuzaki1, Céline Houlle, Claude Darcha, Jean-Luc Pouly, Gérard Mage, Michel Canis.   

Abstract

BACKGROUND: The aim of this study was to identify risk factors for the removal of normal ovarian tissue during laparoscopic cystectomy for endometriosis.
METHODS: A total of 121 patients who had histologically confirmed ovarian endometriosis and 56 control patients who had other histologically confirmed benign cysts were included for the present analysis. The blocks of removed tissue were sectioned at 120 microm intervals and a total of five sections were analyzed for each ovarian cyst. Eight variables (age, pre-operative medical treatment, previous surgery for ovarian endometriosis, single or multiple cysts, size of the largest cyst, side of cyst, co-existence of deep endometriosis, revised American Society for Reproductive Medicine classification) were evaluated using a generalized linear modeling analysis to identify major factors associated with the removal of normal ovarian tissue.
RESULTS: Normal ovarian tissue adjacent to the cyst wall was detected in 71 patients (58.7%) with endometriosis, whereas normal ovarian tissue was removed from only three patients (5.4%) with other benign cysts. A significant factor that was independently associated with the removal of normal ovarian tissue with ovarian endometriosis was pre-operative medical treatment.
CONCLUSIONS: The present retrospective, controlled study suggests that pre-operative medical treatment might be a risk factor for the removal of normal ovarian tissue during laparoscopic cystectomy for ovarian endometriosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246468     DOI: 10.1093/humrep/dep043

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  Clinical management of endometriosis-associated infertility.

Authors:  Yin Mon Khine; Fuminori Taniguchi; Tasuku Harada
Journal:  Reprod Med Biol       Date:  2016-02-17

2.  Poor pregnancy outcome following assisted reproductive technology among women operated on for bilateral endometriomas.

Authors:  Setsuko Yamamoto; Michiko Umeki; Tomoko Maeda; Mina Yamaguchi; Teruhiro Hamano
Journal:  Reprod Med Biol       Date:  2009-11-17

3.  Vasopressin Effect on Operation Time and Frequency of Electrocauterization during Laparoscopic Stripping of Ovarian Endometriomas: A Randomized Controlled Clinical Trial.

Authors:  Marzieh Ghafarnejad; Mina Akrami; Fatemeh Davari-Tanha; Khadijeh Adabi; Sepideh Nekuie
Journal:  J Reprod Infertil       Date:  2014-10

4.  Evaluation of factors predicting diminished ovarian reserve before and after laparoscopic cystectomy for ovarian endometriomas: a prospective cohort study.

Authors:  Rie Ozaki; Jun Kumakiri; Andrea Tinelli; Grigoris F Grimbizis; Mari Kitade; Satoru Takeda
Journal:  J Ovarian Res       Date:  2016-06-21       Impact factor: 4.234

5.  Effect of salpingectomy, ovarian cystectomy and unilateral salpingo-oopherectomy on ovarian reserve.

Authors:  Oybek Rustamov; Monica Krishnan; Stephen A Roberts; Cheryl T Fitzgerald
Journal:  Gynecol Surg       Date:  2016-03-28

6.  Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence.

Authors:  E K Lockyer; Amf Schreurs; McI Lier; Jjml Dekker; I Melgers; V Mijatovic
Journal:  Facts Views Vis Obgyn       Date:  2019-03

7.  Does current ovarian endometrioma increase the time for DOR patients to reach live birth in IVF?

Authors:  Yu Deng; Zhanhui Ou; Minna Yin; Zhiheng Chen; Shiling Chen; Ling Sun
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-15       Impact factor: 3.105

Review 8.  An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women.

Authors:  Sanaz Keyhan; Claude Hughes; Thomas Price; Suheil Muasher
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.